Tag: Medicare coverage

Following its full FDA approval in July 2024, Eli Lilly's Alzheimer's treatment, Kisunla (donanemab), was launched with a list price of $32,000 for a year of treatment. The final cost to patients for this disease-modifying therapy can vary significantly based on treatment duration, insurance coverage, and additional monitoring requirements.

According to data from GoodRx, some Medicare prescription drug plans place brand-name bromfenac on Tier 3 or 4, significantly impacting out-of-pocket costs. The specific insurance tier for **bromfenac** varies widely depending on your individual plan and whether you are prescribed the generic or a brand-name version.

The average annual cost of immunosuppressant medications can range from $10,000 to $14,000 [1.7.1]. This raises a critical question for every transplant recipient: **Do you have to pay for anti-rejection drugs?** While the answer is yes, the amount you pay depends heavily on your insurance and available financial aid.